Prenatal TCDD in mice increases adult autoimmunity

Reproductive Toxicology

Volumn 31, Issue 3, 2011, Pages 312-318

  Holladay, Steven D ^a   Mustafa, Amjad ^a   Gogal, Robert M ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

Autoimmunity; C57BL 6; Developmental; Lupus nephritis; SNF1; TCDD

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; AUTOANTIBODY; CD4 ANTIGEN; COMPLEMENT COMPONENT C3; GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 10;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE DIFFERENTIATION; CD3+ T LYMPHOCYTE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; IMMUNE DEFICIENCY; IMMUNOMODULATION; LYMPHOCYTE COUNT; MALE; MOUSE; NEPHRITIS; NONHUMAN; PHENOTYPE; PRENATAL EXPOSURE; SEX DIFFERENCE;

ANIMALS; AUTOIMMUNE DISEASES; ENVIRONMENTAL POLLUTANTS; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; INTERFERON-GAMMA; INTERLEUKIN-10; KIDNEY; LYMPH NODES; MALE; MATERNAL EXPOSURE; MICE; MICE, INBRED C57BL; NEPHRITIS, INTERSTITIAL; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SEX FACTORS; SPLEEN; T-LYMPHOCYTES; TETRACHLORODIBENZODIOXIN; THYMUS GLAND;

MUS;

EID: 79953757425     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reprotox.2010.08.001     Document Type: Article

References (24)

1. Faith R.E., Moore J.A. Impairment of thymus-dependent immune functions by exposure of the developing immune system to 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Toxicol Environ Health 1997, 3:451-464.
2. Fine J.S., Gasiewicz T., Silverstone A.E. Lymphocyte stem cell alterations following perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Mol Pharmacol 1989, 35:18-28.
3. Holladay S.D., Lindstrom P., Blaylock B.L., Comment C.E., Germolec D.R., Heindel J.J., et al. Perinatal thymocyte antigen expression and postnatal immune development altered by gestational exposure to tetrachlorodibenzo-p-dioxin (TCDD). Teratology 1991, 44:385-393.
4. Gehrs B.C., Smialowicz R.J. Persistent suppression of delayed-type hypersensitivity in adult F344 rats after perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicology 1999, 134:79-88.
5. Greenlee W.F., Dold K.M., Irons R.D., Osborne R. Evidence for direct action of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on thymic epithelium. Toxicol Appl Pharmacol 1985, 79:112-120.
6. Schuurman H.-J., Van Loveren H., Rozing J., Vos J.G. Chemicals trophic for the thymus: risk for immunodeficiency and autoimmunity. Int J Immunopharmacol 1992, 14:369-375.
7. DeWaal E.J., Schuurman H.-J., Loeber J.G., Van Loveren H., Vos J.G. Alterations in the cortical thymic epithelium of rats after in vivo exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): an (immuno)histological study. Toxicol Appl Pharmacol 1992, 115:80-88.
8. Fisher M.T., Nagarkatti M., Nagarkatti P.S. 2,3,7,8-Tetrachlorodibenzo-p-dioxin enhances negative selection of T cells in the thymus but allows autoreactive T cells to escape deletion and migrate to the periphery. Mol Pharmacol 2005, 67:327-335.
9. Blaylock B.L., Ahmed S.A., Holladay S.D. Perinatal immunotoxicant exposure and postnatal autoimmune disease. Developmental immunotoxicology 2005, 215-228. CRC Press, New York. S.D. Holladay (Ed.).
10. Silverstone A.E., Frazier D.E., Gasiewicz T.A. Alternate immune system targets for TCDD: lymphocyte stem cells and extrathymic T-cell development. Exp Clin Immunogenet 1994, 11:94-101.
11. Meyer O. Interferons and autoimmune disorders. Joint Bone Spine 2009, 76:464-473.
12. Roep B.O., Kleijwegt F.S., van Halteren A.G., Bonato V., Boggi U., Vendrame F., et al. Islet inflammation and CXCL10 in recent-onset type 1 diabetes. Clin Exp Immunol 2010, 159:338-343.
13. Shimohata H., Yamada A., Yoh K., Ishizaki K., Morito N., Yamagata K., et al. Overexpression of T-bet in T cells accelerates autoimmune glomerulonephritis in mice with a dominant Th1 background. J Nephrol 2009, 22:123-129.
14. Wang Y., Ito S., Chino Y., Goto D., Matsumoto I., Murata H., et al. Laser microdissection-based analysis of cytokine balance in the kidneys of patients with lupus nephritis. Clin Exp Immunol 2010, 159:1-10.
15. Fine J.S., Silverstone A.E., Gasiewicz T.A. Impairment of prothymocyte activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Immunol 1990, 144:1169-1176.
16. Holladay S.D., Smialowicz R.J. Development of the immune system: differential effects depending on time of exposure. Environ Health Perspect 2000, 108(Suppl. 3):463-473.
17. vonBoehmer H., Melchers F. Checkpoints in lymphocyte development and autoimmune disease. Nat Immunol 2010, 11:14-20.
18. + pre-naïve B cell population. J Immunol 2009, 182:4116-4126.
19. Zandvoort A., Timens W. The dual function of the splenic marginal zone: essential for initiation of anti-T1-2 responses but also vital in the general first-line defense against blood-borne antigens. Clin Exp Immunol 2002, 130:4-11.
20. Lim B.J., Hong S.W., Jeong H.J. IgG nephropathy-confusion and overlap with Cq nephropathy. Clin Nephrol 2009, 72:360-365.
21. Mohan C., Adams S., Stanik V., Datta S.K. Mucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J Exp Med 1993, 177:1367-1381.
22. 1 mice. Birth Defects Res A: Clin Mol Teratol 2009, 85:828-836.
23. Mustafa A., Holladay S.D., Goff M., Witonsky S., Kerr R., Reilly C., et al. An enhanced postnatal autoimmune profile in 24 week-old C57BL/6 mice developmentally exposed to TCDD. Toxicol Appl Pharmacol 2008, 232:51-59.
24. 1 mice. Toxicol Sci 2009, 112:133-143.